UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS.
How ecstasy and psilocybin are shaking up psychiatry.
ecstasy and psilocybin are shaking up psychiatry
Webinar on psychedelics & healing relationships with Dr. Anne Wagner
psychedelics & healing relationships
A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder
ketamine administration for chronic posttraumatic stress disorder
Use of psilocybin (“mushrooms”) among US adults: 2015–2018
Use of psilocybin (“mushrooms”) among US adults
MindMed announces the start of the first-ever clinical trial combining MDMA and LSD.
clinical trial combining MDMA and LSD
Pharmacological-assisted Psychotherapy for Post-Traumatic Stress Disorder: a systematic review and meta-analysis.
Pharmacological-assisted Psychotherapy for Post-Traumatic Stress Disorder
Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD
Development of the Psychological Insight Questionnaire
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants
Classic serotonergic psychedelics for mood and depressive symptoms
Drug Science symposium this Tuesday: Women in psychedelic science - part 2
Drug Science symposium, women in psychedelic science
Psychedelics in psychiatry: neuroplastic, immunomodulatory, and neurotransmitter mechanisms.
Psychedelics in psychiatry: neuroplastic, immunomodulatory, and neurotransmitter mechanisms.
Consciousness, religion, and gurus: Pitfalls of psychedelic medicine.
Consciousness, religion, and gurus: Pitfalls of psychedelic medicine
Development and evaluation of a therapist training program for psilocybin therapy for treatment-resistant depression in clinical research.
Development and evaluation of a therapist training program for psilocybin therapy
Towards psychedelic apprenticeship: Developing a gentle touch for the mediation and validation of psychedelic-induced insights and revelations.
mediation and validation of psychedelic-induced insights
MAPS report successful outcome of their first phase 3 trial of MDMA-assisted therapy for PTSD
MAPS completes successful phase 3 study of MDMA for PTSD